Skip to main content

UBS Group AG

Position in TXMD — TherapeuticsMD, Inc.

CIK 1610520 ZURICH, V8

Position in TXMD

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$10,297
+$9,630 QoQ
Shares Held
4,660
+1307.9% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 45 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in TXMD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

UBS Group AG holds $1,471,515,542 across 82 Drug Manufacturers - Specialty & Generic names. TXMD ranks #67 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TXMD

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,297 4,660
2026-03-31 $667 331
2025-12-31 $1,814 1,114
2025-09-30 $389 362
2025-06-30 $5,221 4,502
2025-03-31 $162 175
2024-12-31 $1,729 2,012
2024-09-30 $8,045 4,847
2024-06-30 $14,676 9,116
2024-03-31 $17,893 7,814
2023-12-31 $2,861 1,272
2023-09-30 $2,104 697
2023-06-30 $9,772 2,372
2023-03-31 $20,661 5,510
2022-12-31 $1,765 316
2022-09-30 $577 87
2022-06-30 $180,422 18,133
2022-03-31 $1,924 5,064
2021-12-31 $7,303 20,288
2021-09-30 $13,626 18,414
2021-06-30 $40,923 34,390
2021-03-31 $27,515 20,534
2020-12-31 $37,865 31,294
2020-09-30 $83,915 53,111
2020-06-30 $122,834 98,268
2020-03-31 $49,685 46,873